絞り込み

16642

広告

Treatment Intensification in Patients With Kawasaki Disease and Coronary Aneurysm at Diagnosis.

著者 Dionne A , Burns JC , Dahdah N , Tremoulet AH , Gauvreau K , de Ferranti SD , Baker AL , Son MB , Gould P , Fournier A , Newburger JW , Friedman KG
Pediatrics.2019 May 02 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (16view , 0users)

Full Text Sources

Coronary artery aneurysms (CAA) are a serious complication of Kawasaki disease. Treatment with intravenous immunoglobulin (IVIg) within 10 days of fever onset reduces the risk of CAA from 25% to <5%. Corticosteroids and infliximab are often used in high-risk patients or those with CAA at diagnosis, but there are no data on their longer-term impact on CAA.
PMID: 31048414 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード